Anvilab Overview
- Year Founded
-
2007

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Anvilab General Information
Description
Manufacturer of generic pharmaceutical products. The company owns the rights to sell Antigrippin-Maximum, Gepagard, and Inflyunet, pharmaceutical brands and owns the trademark Laborotoria ANVI. It develops life saving drugs for chemotherapy, antiviral and others.
Contact Information
Website
www.anvilab.ruCorporate Office
- Kashirskoye Sh. 22, Building 4
- Moscow
- Russia
Corporate Office
- Kashirskoye Sh. 22, Building 4
- Moscow
- Russia
Anvilab Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Anvilab FAQs
-
When was Anvilab founded?
Anvilab was founded in 2007.
-
Where is Anvilab headquartered?
Anvilab is headquartered in Moscow, Russia.
-
What industry is Anvilab in?
Anvilab’s primary industry is Pharmaceuticals.
-
Is Anvilab a private or public company?
Anvilab is a Private company.
-
What is the current valuation of Anvilab?
The current valuation of Anvilab is
. -
What is Anvilab’s current revenue?
The current revenue for Anvilab is
. -
When was Anvilab acquired?
Anvilab was acquired on 06-Jul-2011.
-
Who acquired Anvilab?
Anvilab was acquired by Protek (Distribution & Retail).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »